ON SERUM PROTEIN COMPONENTS AND LEUCOCYTE PERCENTAGE OF ERYTHEMA NODOSUM LEPROSUM

Erythema nodosum leprosum.

Clinical observations on erythema nodosum leprosum (E.N.L.).

The nodules were sometimes the exacerbation of existing lesions, or sometimes the eruption of fresh lesions. The nodules themselves varied from about the size of a pea to about the size of a shilling, and they were usually tender on pressure. Ankaful Leprosarium is the headquarters of the Ghana Leprosy Service and is situated 6 miles from the coast and is 1 00 miles west of Accra. It admits pri...

Etanercept in erythema nodosum leprosum*

One of the biggest challenges in treating leprosy is the control of reaction events. Patients with lepromatous leprosy may present reaction type II, or erythema nodosum leprosum, during treatment, and this reaction can remain in a recurrent form after being released from the hospital, requiring the use of thalidomide and/or prednisone for long periods of time, in turn increasing the risk of sid...

Erythema nodosum leprosum and orbital involvement.

This is the first report of ENL involving the orbit in a lepromatous patients with recurrent ENL, receiving MDT. Severe injury to the eye ensued, in spite of continued ENL and appropriate treatment of the reaction.

Erythema nodosum leprosum research: ENLISTing support.

Understanding and managing leprosy reactions and their associated nerve function impairment remain a research priority for WHO and form part of the International Federation of Anti Leprosy Associations (ILEP) Strategy 2015-18. We still lack the tools to predict who will develop these serious complications which lead to nerve function impairment, disability and other long term sequelae, such as ...